glp 1 afib New research presented at #HRS2026 finds #GLP1 medications may reduce the risk of #AFib — independent of weight loss. The findings suggest these therapies may influence heart rhythm through mechanisms beyond weight GLP-1 RAs Probably Don't Boost

\n\n\n\n Importantly, BPC-157 has not been found to significantly raise or lower blood pressure in healthy animal models, and it does not appear to disrupt hormonal axes in ways that would suggest meaningful endocrine system interference

REDOX imbalance is emerging as an important, underappreciated mechanism across neurodevelopmental, neuropsychiatric, and neurological conditions

Anti-doping organizations learned long ago that they could never keep up with the pace of pharmaceutical and chemical innovation if they had to list every single prohibited molecule by its chemical name

Allergies or Sensitivities: Disclose any history of allergies or adverse reactions to medications administered via injection

Bacteriostatic water is generally preferred for multi-dose vials because it contains a preservative

Are you injecting the water too forcefully